Parameswaran Hari

Company: Iovance Biotherapeutics
Job title: SVP, Clinical Science
Seminars:
Improving the Efficacy of Adoptive T Cell Therapy by Leveraging the Polyclonality of TIL 4:30 pm
• Efficacy of polyclonal TIL: current data in solid tumors • What’s next: genetically modified TIL • Ensuring success and access to TIL therapyRead more
day: Day One